Home › Funds › DV EQUITIES, LLC › DNTH

DV EQUITIES, LLC position in DNTH

DIANTHUS THERAPEUTICS INC · Health Care

DV EQUITIES, LLC reported holding 21,051 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.36% of its reported portfolio and ranking #37 among its reported holdings. DV EQUITIES, LLC has disclosed DNTH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)21.05K sh
Reported value held$1.85M
Portfolio Weight0.36%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DV EQUITIES, LLC's DNTH position evolved

DV EQUITIES, LLC first disclosed a stake in DNTH in Q2 2026 at 21,051 shares (US$2.1M). Across 2 filings, DV EQUITIES, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 21,051 shares valued at US$1.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 21.05K $2.05M New
Q3 2026 21.05K $1.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$223.4M), Avidity Partners Management LP (US$167.3M), Octagon Capital Advisors LP (US$148.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has DV EQUITIES, LLC held DNTH?

DV EQUITIES, LLC has disclosed DNTH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is DV EQUITIES, LLC's current position in DNTH?

As of Q3 2026, DV EQUITIES, LLC holds 21.05K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $1.85M, representing 0.36% of its reported portfolio and ranking #37.

Has DV EQUITIES, LLC been buying or selling DNTH?

In the latest 13F filing (Q3 2026), DV EQUITIES, LLC held unchanged its position in DNTH.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.